← Back to Search

Text Messaging and Peer Navigation for Medication Adherence

N/A
Waitlist Available
Led By Joanne Stekler, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This study is evaluating whether text messages and peer navigation may help improve PrEP use among individuals who use methamphetamine.

Eligible Conditions
  • Medication Adherence
  • HIV/AIDS
  • Substance Use

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability and impact of text messaging intervention.
Acceptability of text messaging intervention
Secondary outcome measures
PrEP adherence
PrEP persistence

Trial Design

4Treatment groups
Active Control
Group I: Text Messaging and Peer NavigationActive Control2 Interventions
Participants in this group will receive both the text messaging and peer navigation interventions.
Group II: Standard of CareActive Control1 Intervention
Participants in this group will receive the standard of care for PrEP follow-up and no additional research interventions.
Group III: Text MessagingActive Control1 Intervention
Participants in this group will receive the text messaging intervention.
Group IV: Peer NavigationActive Control1 Intervention
Participants in this group will receive the peer navigator intervention.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,553 Total Patients Enrolled
University of WashingtonLead Sponsor
1,738 Previous Clinical Trials
1,844,311 Total Patients Enrolled
Joanne Stekler, MDPrincipal Investigator - University of Washington
Harborview Medical Center, University of Washington Medical Center
Duke University School Of Medicine (Medical School)
University Of Wa School Of Medicine (Residency)
1 Previous Clinical Trials
9 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
PLoS ONEJournal
Text Message Intervention Designs to Promote Adherence to Antiretroviral Therapy (ART): A Meta-analysis of Randomized Controlled Trials
Finitsis, David J., Jennifer A. Pellowski, and Blair T. Johnson. 2014. “Text Message Intervention Designs to Promote Adherence to Antiretroviral Therapy (ART): A Meta-analysis of Randomized Controlled Trials”. Edited by Alan Winston. Plos ONE. Public Library of Science (PLoS). doi:10.1371/journal.pone.0088166.
clinicaltrials.govStudy
Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users
Joanne Stekler, MD MPH 2018. "Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03584282.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top